Hormones control essential processes like growth, metabolism, mood, and reproduction, but when their balance is disrupted, it ...

Credit: Getty Images We spoke with endocrinologists to explore the potential of artificial intelligence in the management of chronic disease, including diabetes, obesity, and PCOS. Artificial ...

Amylyx Pharmaceuticals Inc. (NASDAQ:AMLX) is one of the overlooked growth stocks to buy. On January 8, Amylyx Pharmaceuticals ...

A team of researchers has discovered a new method of measuring levels of cortisol directly from a blood sample, and this marks a significant step forward in diagnosis and treatment of a wide range of ...

When these hormones become imbalanced, it can lead to the development of an endocrine disorder. “An endocrine disorder occurs when your body produces either too much or too little of a particular ...

The study will be conducted in three phases. Part A is a Phase 2, open-label, semi-sequential dose-ranging portion of the ...

Endocrine disorders happen when hormone levels are too high or too low. Fatigue and mood changes are common symptoms of many endocrine disorders. Diabetes is the most common endocrine disorder in the ...

The paper, titled, "Weekly Subcutaneous VK2735, a GIP/GLP-1 Receptor Dual Agonist, for Weight Management: Phase 2, Randomized, 13-Week VENTURE Study," was published in Obesity, the peer-reviewed ...

I am thrilled to welcome Laurie Stelzer to the Company’s Board as an independent director,” said Kent Hawryluk, President and Chief Executive Officer of MBX Biosciences. “Laurie adds significant ...

Please provide your email address to receive an email when new articles are posted on . There are limited numbers of FDA-approved medications to treat alcohol and substance use disorders. Preclinical ...

In August 2025, Nxera announced the launch of a broad proprietary pipeline advancing next-generation, best-in-class therapies for obesity and metabolic disorders. Nxera’s pipeline is designed to ...